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Abstract
Background: Endocrine mechanisms governing canine reproductive function remain still obscure. Progesterone
(P4) of luteal origin is required for maintenance of pregnancy. Corpora lutea (CL) are gonadotrop-independent
during the first third of dioestrus; afterwards prolactin (PRL) is the primary luteotropic factor. Interestingly, the
increasing PRL levels are accompanied by decreasing P4 concentrations, thus luteal regression/luteolysis occurs in
spite of an increased availability of gonadotropic support. PRL acts through its receptor (PRLr), the expression of
which has not yet been thoroughly investigated at the molecular and cellular level in the dog.
Methods: The expression of PRLr was assessed in CL of non-pregnant dogs during the course of dioestrus (days 5,
15, 25, 35, 45, 65 post ovulation; p.o.) as well as in CL, the utero/placental compartments (Ut/Pl) and interplacental
free polar zones (interplacental sites) from pregnant dogs during the pre-implantation, post-implantation and mid-
gestation period of pregnancy and during the normal and antigestagen-induced luteolysis. Expression of PRLr was
tested by Real Time PCR, immunohistochemistry and in situ hybridization.
Results: In non-pregnant CL the PRLr expression was significantly upregulated at day 15 p.o. and decreased
significantly afterwards, towards the end of dioestrus. CL of pregnancy showed elevated PRLr expression until mid
gestation while prepartal downregulation was observed. Interestingly, placental but not interplacental expression of
PRLr was strongly time-related; a significant upregulation was observed towards mid-gestation. Within the CL PRLr
was localized to the luteal cells; in the Ut/Pl it was localized to the fetal trophoblast and epithelial cells of glandular
chambers. Moreover, in mid-pregnant animals treated with an antigestagen, both the luteal and placental, but not
the uterine PRLr were significantly downregulated.
Conclusions: The data presented suggest that the luteal provision of P4 in both pregnant and non-pregnant dogs
may be regulated at the PRLr level. Furthermore, a role of PRL not only in maintaining the canine CL function but
also in regulating the placental function is strongly suggested. A possible functional interrelationship between
luteal P4 and placental and luteal PRLr expression also with respect to the prepartal luteolysis is implied.
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Background
Regulation of reproductive function in the domestic dog
(Canis familiaris) is governed by many, as yet not fully
understood, species-specific mechanisms. Most of the
knowledge available so far relates to clinical observations.
Thus, the production of progesterone of follicular origin
is observed already prior to ovulation at the end of proes-
trus and reaches the levels of about 5 ng/ml in peripheral
blood plasma at the time of ovulation [1]. The Corpus
luteum (CL) phase and, associated with it, luteal proges-
terone secretion is virtually identical in pregnant and cyc-
lic animals until shortly before parturition [1,2]. Hence,
during the formation of the CL (until day 15-20 post ovu-
lation) a strong rise in the concentration of peripheral
progesterone levels takes place. Afterwards, progesterone
levels start to decrease gradually until approximately day
60 of the luteal life-span when a steep prepartal proges-
terone decline is observed in pregnant animals (prepartal
luteolysis) as a prerequisite for parturition [3]. In non-
pregnant dogs in contrast, there is a progressive decrease
of progesterone levels during the extended luteal regres-
sion that can last for up to 1-3 months until the periph-
eral P4 will eventually reach levels < 1 ng/ml and the
cycle enters anoestrus [1,2,4,5]. Interestingly and in con-
trast to polyestrus species (e.g. cattle, pig), where ovarian
cyclicity depends upon the periodic production of the
endometrial luteolysin (PGF2a), at least in non-pregnant
bitches, the uterus does not regulate luteal function since
normal ovarian function is observed following hysterect-
omy [6,7]. In pregnant dogs, however, the prepartal pro-
gesterone decline coincides with an increase in PGF2a
levels in maternal blood [3]. This seems to originate from
the dramatically increased expression of cyclooxygenase
2 (COX2) in the fetal trophoblast [8] and strongly implies
a functional role of PGF2a in relation to the onset of par-
turition [3]. The withdrawal of progesterone and altera-
tions in the feto-maternal communication at the level of
maternal decidual- and fetal trophoblast cells seem to
play a signalling role in this process [8]. The observation
that antigestagen-mediated blocking of progesterone
receptors results in the activation of an endocrine cas-
cade within the luteal and placental prostaglandin system
similar to that observed during normal prepartal luteoly-
sis further supports this hypothesis [8,9].
Mechanisms regulating corpus luteum function, both in
pregnant and non-pregnant bitches, have been widely dis-
cussed. During the first 2-6 weeks of dioestrus the gonado-
tropic support is not required for luteal maintenance
[10-12]. Recently, a possible luteotropic role for prosta-
glandin E2 (PGE2) produced locally, within the corpus
luteum (CL) during this period of time has been suggested
[13]. Thereafter, in the second half of pregnancy, hypophy-
sectomy, and hence deprivation of gonadotropic support
leads to cessation of luteal function [10-12]. Serum
concentrations of PRL remain mostly low during the first
half of pregnancy, at approximately 5-6 weeks of gestation
they begin to increase constantly towards parturition [14].
In non-pregnant animals serum concentrations of PRL
remain low during most of the course of dioestrus and
increase 2 to 3 fold around day 50 post ovulation, which is
the time when parturition would have occurred [7,14,15].
Similarly, an increased availability of the luteinizing
hormone (LH) has been observed in bitches when P4 con-
centrations were declining during the course of dioestrus
[6,16]. Therefore, the luteal regression and/or luteolysis
occurs in spite of an increased availability of gonadotropic
support.
In contrast to species in which provision of LH seems
to be essential for luteal function, e.g. cattle [17], pigs
[18] and horses [19], in the dog PRL appears to be the
main gonadotropic factor involved in maintenance of the
CL function, and hence pregnancy from the second third
of dioestrus onwards [11,20,21]. While sensitivity of the
canine ovary to prolactin withdrawal can occur as early
as at day 25 after the preovulatory LH peak and can lead
to permanent luteal regression [22], blocking of LH func-
tion results only in a transient progesterone decrease,
both in pregnant and non-pregnant animals [11,23]. LH
does not seem to stimulate progesterone secretion
directly but, especially during the late luteal phase, it is
capable of increasing prolactin concentrations [23]. From
this observation a possible indirect role of LH in regulat-
ing canine luteal function acting as a mediator in PRL
secretion has been suggested [23]. On the other side
neither a direct stimulatory effect of PRL on plasma pro-
gesterone secretion nor a noticeable effect on plasma LH
levels was seen [21]. Thus, although PRL appears to be
an essential luteotropin from mid-luteal phase in both
pregnant and non-pregnant dogs, its role seems to be
directed more towards slowing down luteal regression
than stimulating progesterone production [21].
PRL acts through the PRL receptor (PRLr), a single
membrane-bound protein of the class 1 of the cytokine/
PRL/GH receptor family [24,25]. Several isoforms of PRLr
have been identified in different tissues of mammals (see
reviewed by [26]). For example in the rat there are three
major PRLr isoforms; the short, intermediate and long one
have been described [26]. In mice three short and one
long isoform [27], in cattle one short and one long [28,29],
and in humans five isoforms are known [30]. The different
PRLr isoforms can result from utilizing different PRLr pro-
moters for initializing of transcription as well as can be
expressed as alternative splice variants [31,32]. The differ-
ent length and structure, especially concerning the intra-
cellular domain of the PRLr isoforms, as well as the ratio
of short to long isoforms, result in altered signalling prop-
erties and determine the tissues sensitivity to PRL [33,34].
Among the various signalling cascades that are activated
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through this receptors family, activation of tyrosine kinases
of the Janus kinase (JAK) family and subsequent phos-
phorylation/activation of the cytoplasmic signal transdu-
cers and activators of transcription (STATs) is considered
the major signalling pathway [26,33].
The presence of that many isoforms of the PRLr indi-
cates multiple possibilities for their involvement in regu-
lating endo-, para- and/or autocrine functions of
targeted organs. They are probably also characterized by
a high species dependent diversity.
As for the dog, and concerning the presence of PRLr in
canine reproductive tissues, Fernandes et al. [15] reported
about the concentrations of the binding sites for prolactin
in the luteal membranes isolated from tissue homogenates
obtained from non-pregnant dogs during the course of
dioestrus. They tended to be maximal during the first
40 days of the luteal life-span and were generally lower
thereafter, when serum and luteal concentrations of P4
were decreasing [15]. Concomitantly with the decrease of
peripheral P4 levels a decrease in expression of the steroi-
dogenic acute regulatory protein (StAR) occurs [9,35].
This suggests that production of the luteal P4 in dog
might be controlled by the substrate provision at the level
of cholesterol transfer from the outer to the inner mito-
chondrial membrane. The role of the upstream operating
regulatory factors, however, remains open and needs to be
elucidated. Since, acting through its receptor, PRL is a
vital luteotropic hormone from the mid-luteal phase in the
dog, PRLr obviously becomes one of the possible candi-
dates. To our knowledge its expression in canine repro-
ductive tissues has not yet been investigated at the
molecular and cellular level. Therefore, the current study
was undertaken to obtain first information on the expres-
sion and localization of the PRLr in canine CL from
pregnant and non-pregnant dogs. Even if devoid of steroi-
dogenic capacity [1], canine placenta appears to be an
endocrine organ actively responding to the circulating pro-
gesterone levels [8] and showing thereby an immediate
functional interrelationship with CL-derived steroids.
Hence, in order to test if canine placenta could be a possi-
ble target for PRL we have also investigated the spatio-
temporal expression of PRLr in the utero-placental com-
partments (Ut/Pl).
Methods
Tissue collection and preservation
Clinically healthy and sexually mature bitches of various
breeds (aged 2-8 years) were used for this study. All
experiments were in accordance with the respective ani-
mal welfare legislation ((permit no. II 25.3-19c20-15c GI
18/14 and VIG3-19c-20/15c GI 18,14 (Justus-Liebig
University, Giessen) and permit no. Ankara 2006/06
(Faculty of Veterinary Medicine, University of Ankara)).
Non-pregnant bitches
Groups of five bitches each were ovariohysterectomized
on days 5, 15, 25, 35, 45 and 65 after ovulation (p. o.).
Ovarian function was monitored by determining P4 in
2-3 day intervals. The day of ovulation was defined as
the day when plasma progesterone concentration
reached 5 ng/mL [1].
Pregnant bitches
Animals were divided into four groups and subjected to
ovariohysterectomy at following days of pregnancy: 8-12
(pre-implantation; n = 5), 18-25 (post-implantation; n =
5), 35-45 (mid-gestation; n = 5) and prepartal luteolysis;
n = 3.
For all bitches the day of mating (day 0) was recorded.
In the pre-implantation group pregnancy was confirmed
by detecting embryos in uterine flushing. For the pre-
partal luteolysis - group, P4 was determined every 6 h
from day 58 of pregnancy on; at P4 levels continuing to
decrease below 3 ng/ml within two consecutive mea-
surements ovariohysterectomy was performed.
Additionally, mid-pregnant dogs (days 40-45 of preg-
nancy, n = 10) were treated with the antiprogestin Agle-
pristone® [10 mg/Kg bw (2×/24 hrs apart)]. In this
group ovariohysterectomy was performed 24 hrs and 72
hrs after the 2nd treatment.
Immediately after ovariohysterectomy Corpora lutea
(CL) from pregnant and non-pregnant animals as well as
the utero/placental compartments (Ut/Pl) and samples
from the interplacental free polar zones of animals
sampled at the post-implantation and mid-gestation peri-
ods were trimmed off the surrounding connective tissues
(there was no tissue material available for the experiments
from the interplacental sites from dogs during prepartal
luteolysis). The tissue samples were then incubated for
24 h in RNAlater® (Ambion Biotechnologie GmBH, Wies-
baden), an aqueous reagent for stabilization of cellular
RNA (ratio mass:volume = 1:6) and subsequently stored at
-80°C until total RNA isolation. For immunohistochemis-
try (IHC) and In situ hybridization (ISH) samples were
fixed in 10% neutral phosphate buffered formalin for 24 h,
frequently washed with PBS during one week, dehydrated
in a graded ethanol series and embedded in paraffin-
equivalent Histo-Comp (Vogel; Giessen, Germany).
As already published in [36] and kindly provided by
Dr. Paula Papa of the Sector of Anatomy of the Faculty
of Veterinary Medicine of the University of Sao Paulo
the corresponding peripheral progesterone levels in
non-pregnant animals were: 41.3 ± 11.7 ng/ml at day 5
p.o., 53.7 ± 2.6 ng/ml at day 15 p.o., 42.0 ± 20.6 ng/ml
at day 25 p.o., 30.1 ± 4.31 ng/ml at day 35 p.o. and
22.9 ± 5.9 at day 45 p.o.. Here we extended the data
including day 65 p.o. with expected low progesterone
levels (6.4 ± 1.59 ng/ml). For the pregnant animals
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following corresponding mean progesterone concentra-
tions were shown in [9]; 35.71 ± 7.9 ng/ml in the
pre-implantation period, 29.73 ± 13.23 ng/ml in the
post-implantation period, 13.32 ± 8.66 ng/ml at mid-
gestation and 2.07 ± 0.99 ng/ml during the prepartal
progesterone decline. After Alizine® application and as
presented in [9]: before the first treatment 15.11 ±
6.7 ng/ml; at the second Aglepristone treatment 13.61 ±
8.2 ng/ml; 5.1 ± 2.7 ng/ml 24 h later and 2.33 ± 1.44 ng/
ml, respectively 1.2 ± 0.6 ng/ml 48 and 72 h later.
RNA isolation and homology cloning of canine-specific
partial prolactin receptor (PRLr) sequence
Trizol®-Reagent (Invitrogen, Carlsbad, CA) was used to
isolate total RNA from CL and Ut/Pl compartments.
Subsequently, DNase-treatment with RQ1 RNase-free
DNase (Promega, Dübendorf, CH) was performed to
eliminate genomic DNA contaminations. Both proce-
dures were according to the manufacturers’ instructions.
Reverse transcription reagents were purchased from
Applied Biosystems, Foster City, CA, USA; random hex-
amers were used as primers for the cDNA synthesis. Of
each sample 100 ng of DNase-treated total RNA were
used. Reactions were carried out in an Eppendorf Master-
cycler Thermal Cycler (Vaudaux-Eppendorf AG, Basel,
CH) using our previously published protocol [37].
To date the canine-specific PRLr sequence has not yet
been characterized. Thus, alignment of the known PRLr
homologues with an online available genomic sequence
was performed in order to derive the canine-specific pri-
mers for PRLr. Using the primer pair: forward 5’-GTG
GGA GAC TCA TTT TGC TG-3’ and reverse 5’-CGA
AGT AGG GGA TTT TGC C-3’, a 689 bp PCR frag-
ment of partial canine PRLr was succesfully amplified
(Figure 1). The annealing temperature was 56°C. The
hot start PCR reaction with the GeneAmp Gold RNA
PCR Kit (Applied Biosystem, Foster City, CA, USA) was
according to the previously published protocol [37].
Primers were ordered from Microsynth AG, Balgach,
CH. After separation on a ethidium bromide stained 2%
agarose gel, PCR products were purified using the Qiaex
II gel extraction system (Qiagen GmbH Hilden,
Germany), ligated into a pGEM-T vector (Promega,
Dübendorf, CH), transformed and amplified in XL1
BLUE competent cells (Stratagene, la Jolla, CA, USA)
and finally sequenced on both strands (Microsynth,
Balgach, CH) with T7 and Sp6 sequencing primers.
Autoclaved water instead of RNA and the so-called RT
minus controls were used as negative controls. Integrity
of RNA and the assay procedure were tested by amplifi-
cation of the housekeeping gene Gapdh using following
primers: forward: 5’-GCT GCC AAA TAT GAC GAC
ATC A-3’and reverse: 5’-GTA GCC CAG GAT GCC
TTT GAG-3’. For positive control a PCR reaction was
performed using total RNA isolated from canine pitui-
tary gland confirming the identity of the CL- and Ut/Pl-
isolated sequence with the hypohysal PRLr. Finally, the
cloned sequence was submitted to the GenBank with
accession number: HQ267784: Canis lupus familiaris
prolactin receptor mRNA, partial cds.
Semi-quantitative RT-PCR and data evaluation
The semi-quantitative Real Time (Taq Man) PCR was
performed using an automated fluorometer ABI PRISM®
7500 Sequence Detection System (Applied Biosystems,
Foster City, CA) according to our previously described
protocol [37]. DNase-treatment and cDNA synthesis as
well as negative controls were as for qualitative PCR.
Samples were run in duplicates with Fast Start Universal
Probe Master (ROX) ® from Roche Diagnostics. Three
different independent endogenous references (GAPDH,
18SrRNA and cyclophilin A) were used for the semi-
quantitation protocol. The primers and probes sequences
were as follows: Prlr (forward): 5’-GGA TCT TTG TGG
CCG TTC TTT-3’, Prlr (reverse): 5’-AAG GAT GCA
GGT CAC CAT GCT AT-3’, Prlr (TaqMan Probe): 5’-A
TT ATG GTC GTA GCA GTG GCT TTG AAA GGC-3’
(gene bank accession number HQ267784); Gapdh (for-
ward): 5’-GCT GCC AAA TAT GAC GAC ATC A-3’,
Gapdh (reverse): 5’-GTA GCC CAG GAT GCC TTT
GAG-3’, Gapdh (TaqMan Probe): 5’-TCC CTC CGA
TGC CTG CTT CAC TAC CTT-3’ (gene bank accession
number AB028142); 18SrRNA (forward): 5’-GTC GCT
CGC TCC TCT CCT ACT-3’, 18SrRNA (reverse): 5’-
GGC TGA CCG GGT TGG TTT-3’, 18SrRNA (TaqMan
Probe): 5’-ACA TGC CGA CGG GCG CTG AC-3’ (gene
bank accession number FJ797658). The primers and the
6-carboxyfluorescein (6-FAM) and 6-carboxytetra-
methylrhodamine (TAMRA) labelled probes were from
Microsynth, Balgach, CH. The commercially available
M 1kb       Pituitary           CL
1         2 1         2
689bp
72bp
Figure 1 Expression of canine PRLr (1) and GAPDH (2) in
anterior pituitary (positive control) and corpus luteum by
conventional RT-PCR. The amplified PRLr fragments were used for
the cloning procedure.
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canine specific cyclophilin A TaqMan Gene Expression
Assay was ordered from Applied Biosystems, Foster City,
CA, USA (Prod. No. Cf03986523-gH).
Measurement of the efficiency of the PCR reactions
using the CT slope method and the relative quantifica-
tion of PRLr expression using the comparative CT
method (ΔΔCT) were according to previously described
protocols [37,38]. In order to confirm the specificity of
the PCR reaction, selected PCR products were commer-
cially sequenced (Microsynths, Balgach, CH).
To test for an effect of the observational group on
PRLr mRNA-levels, a parametric one-way analysis of
variance (ANOVA) was applied. In case of p < 0.05 mul-
tiple comparison post-tests were performed. Those were:
Tukey-Kramer multiple comparison test in experiments
showing the expression of PRLr during the course of
pregnancy and in luteal samples from non-pregnant
dogs and Dunnett’s multiple comparison test in experi-
ments showing the PRLr expression after Aglepristone®-
induced luteolysis. In the latter the results present the
fold change in PRLr expression compared to its mRNA-
levels at mid-gestation. Numerical data were presented
as the mean ± standard deviation. For all tests statistical
software program, GraphPad 3.06 (GraphPad Software,
Inc., San Diego, California, USA) was used.
Immunohistochemical detection of prolactin receptor
(PRLr)
The standard immunoperoxidase detection method was
as previously described [37,39]. The antiserum (dilution
1:50) was polyclonal goat antigen affinity-purified IgG
fraction against human PRLr, R&D Systems Europe Ltd.
Goat IgG irrelevant antibodies I-5000 from Vector
Laboratories Inc., Burlingame, CA94010, CA, USA were
used as the negative/isotype control. Unspecific binding
sites were blocked with 10% horse serum in IHC/0.25%
Triton X buffer. The secondary antibody was the bioti-
nylated horse anti goat IgG BA-9500 from Vector
Laboratories diluted 1:100. The peroxidase activity was
detected with DAB substrate Kit according to the manu-
facturer’s instruction (Dako North America, Inc.).
In situ hybridization (ISH)
PCR products of 280 bp size generated with primers:
forwards: 5’-GTG GGA GAC TCA TTT TGC TG-3’
and reverse: 5’-AGG AAC TGG TGG AAG GAT G-3’
were used as template for subsequent synthesis of cRNA
probes. The PCR products were separated on an agarose
gel, cut out, purified with the Qiaex II gel extraction
system (Qiagen GmbH Hilden, Germany), and cloned
into pGEM-T vector (Promega). After amplifying in
XL1 BLUE competent cells (Stratagene, la Jolla, CA,
USA) plasmids were linearized by single-digestion with
restriction enzymes NcoI and Not (New England
Biolabs, Frankfurt, Germany) for antisense- and sense-
cRNA, respectively. The subsequent non-radioactive ISH
was performed on paraffin-embedded sections of canine
utero/placental section according to the previously pub-
lished protocol [8,39].
Results
Expression of PRLr in Corpus luteum of pregnant and
non-pregnant animals
Canine-specific sequence of PRLr has not been pub-
lished prior to our work. Thus, cloning and sequencing
of canine PRLr-cDNA were a prerequisite before investi-
gating its expression pattern in canine reproductive tis-
sues. The PRLr sequences isolated from luteal and/or
utero/placental tissues were 100% identical with the
sequence retrieved from pituitary.
Expression of PRLr mRNA and protein was detected
in CL of pregnant and non-pregnant dogs at all time
points examined. In non-pregnant dogs expression of
mRNA followed a highly significant effect of time (p <
0.0103). The highest expression was at the beginning of
the dioestrus, at day 15 p.o.. Afterwards, it decreased
gradually and was significantly (p < 0.05) downregulated
by 2.1-fold at day 65 p.o (Figure 2a).
There was also a significant effect of time for the
expression of the luteal PRLr during pregnancy (p <
0.0140). The highest expression was observed during
pre-implantation period (days 8-12) and post-implanta-
tion (days 18-25 of pregnancy) and decreased signifi-
cantly by 2.4-fold (p < 0.05) during prepartal luteolysis
(Figure 2b).
At the protein level as determined by immunohisto-
chemistry, the expression of PRLr was localized mostly
to the luteal cells. Signals were detected at all stages of
the luteal life-span and the staining pattern reflected
that of the mRNA-expression. Thus, the strongest sig-
nals were observed at the beginning and weaker towards
the end of the luteal phase (Figure 3). The weak signals
observed within the blood vessels throughout the luteal
life-span can either be attributed to the lower expression
and hence, detection limit of PRLr in the vessels or to
the background staining.
Expression of PRLr in canine utero/placental
compartment and interplacental polar zones
The expression of PRLr within the utero/placental
compartment was highly time-dependent. (p = 0.0077).
The lowest expression was observed during the pre-
implantation period. With the formation of the pla-
centa levels of PRLr-mRNA started to increase and
reached significantly higher level (p < 0.01) during the
mid-gestation period. The decrease prior to parturition
was not significant (p > 0.05) (Figure 2C). These obser-
vations led us to speculate on the source of this
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increased PRLr-mRNA expression within the utero/
placental compartment coinciding with the intense pla-
cental development and prompted us to investigate the
expression of PRLr-mRNA in the interplacental free
polar zones (uterine compartment). However, as
revealed by the Real Time PCR, no statistically signifi-
cant differences (p > 0.05) were observed for the
expression of the target gene in this compartment in
samples derived from the post-implantation and mid-
gestation period if compared with the pre-implantation
period (Figure 4A).
Prior to implantation strong immunohistochemical
signals were localized to surface and glandular epithelial
cells (Figure 5A, B). Following the implantation and pla-
centation the evenly distributed signals were targeted to
the fetal trophoblast cells and to the epithelial cells of
the glandular chambers (Figure 5C, D). A similar locali-
zation pattern was observed at the mRNA-level by in
situ hybridization (Figure 5E, F).
The effect of antiprogestin treatment on luteal and
placental PRLr expression
Real Time PCR has been applied to test the effects of
antiprogestin treatment on luteal and placental PRLr
expression. Samples from the mid-gestation group
served as non-treated control in the statistical evaluation
with Dunnett’s multiple comparison test. The luteal and
utero/placental expression of PRLr was significantly (p <
0.01) decreased (2.5- and 7.6-fold, respectively) in
response to the treatment with Aglepristone® with more
pronounced effects (p < 0.01) observed at 72 h than at
24 h after the 2nd. application (Figure 6A, B). The uter-
ine PRLr expression was not affected by the antigesta-
gen-treatment (p > 0.05) (Figure 4B).
Discussion
As the canine placenta lacks steroidogenic activity, the
establishment and maintenance of pregnancy depends on
the provision of progesterone of luteal origin. Following
the period of an apparent gonadotropic independence,
especially from the second half of dioestrus, gonadotropic
support is required for proper CL function. While PRL is
the major factor in this process [10,11,20], LH seems to
play a more indirect role, possibly as a mediator of PRL
secretion [23]. Contrasting with this dominant role of
PRL as a luteotropic factor within canine CL is the fact
that the luteal regression and/or luteolysis take place in
presence of increased LH and PRL concentrations in per-
ipheral blood [6,14-16]. This remains also one of the
most interesting peculiarities in mechanisms regulating
canine reproduction.
There are several isoforms of PRLr known in different
species, most of them representing alternative splice var-
iants within the 3’ends of their cDNA sequences
[26,27,32]. Here, using homology cloning, for the first
time, a partial sequence of canine PRLr sequence display-
ing a high similarity (82 - 92%) with respective regions of
other species (mouse, rabbit, pig, cattle, human) has been
cloned and sequenced. It corresponds to the portions of
the extra- and transmembrane domains conserved within
the PRLr isoforms of other species, e.g exons 6-9 in
mouse [27]. Further studies aiming to delineate complete
cDNA of dog-specific PRLr and its potential isoforms
should be considered. Nevertheless, the data presented
provide the first molecular insight in the expression and
localization of PRLr in CL from non-pregnant and preg-
nant dogs as well as in the utero/placental compartment.
As determined on the mRNA- and protein-level, the
luteal and utero/placental expression of PRLr was
strongly time-related. In non-pregnant animals the luteal
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Figure 2 Time-dependent expression of canine prolactin
receptor (PRLr) as determined by Real Time (TaqMan) PCR
(mean ± SD). (A) Cyclic CL, day 5-65 after ovulation. (B) CL of
pregnancy. (C) Utero/placental compartment throughout pregnancy.
Bars with different letters differ either at p < 0.05 (A,B) or at p <
0.01 (C).
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expression was highest at the beginning of dioestrus (day
15 p.o.); the decrease towards day 65 p.o. was significant
(p < 0.05). This observation is seemingly in conflict with
findings of Fernandes et al. [15], who reported about
changes in concentration of unoccupied receptors for
prolactin in canine luteal homogenates, which even
though generally decreased after day 40 of luteal life-
span, were statistically not significant. However, we
Pre-implantation Post-implantation
Mid-pregnancy Prepartal luteolysis
Day 15 p.o. Day 65 p.o.
Figure 3 Immunohistochemical localization of PRLr in canine CL during pregnancy from the pre-implantation period until prepartal
luteolysis and on days 15 and 65 post-ovulation in non-pregnant animals; (open arrowheads) lutein cells.
Kowalewski et al. Reproductive Biology and Endocrinology 2011, 9:109
http://www.rbej.com/content/9/1/109
Page 7 of 11
anticipate that this contradiction may be due to differ-
ences in the detection limits of the methods used in the
two studies. While in the past the determination of PRLr
content in canine luteal tissues based on the binding of
the radiolabeled purified human growth hormone to
luteal homogenates [15], in the present study the very
sensitive Real Time PCR was applied. The identity of
selected amplicons with the hypophyseal PRLr was con-
firmed by sequencing.
Furthermore, the cycle-stage related expression of
PRLr in CL of dioestric dogs resembled the course of P4
concentrations in peripheral plasma and may, hence,
indicate that the provision of P4 in later stages of dioes-
trus could be controlled at the level of PRLr expression
and/or function. Similarly, in pregnant animals the pre-
partal drop of PRLr-mRNA strongly resembled changes
in luteal StAR and 3bHSD expression observed at the
time of prepartal luteolysis [9]. Whether the decreased
PRLr levels are the trigger or the result of luteolysis
remains to be elucidated. However, since PRL acting
through its receptor operates upstream of the steroido-
genic machinery, the PRLr-mediated decline in luteal
responsivity to PRL could be one of the triggers of
luteolysis.
By investigating mechanisms involved in controlling
reproductive function, recently, a new focus has been put
on canine placenta as an important endocrine organ in
this species [8,38]. Especially with respect to the prepartal
luteolysis the placenta seems to be capable of actively
responding to changes in the circulating P4 by activating
of the enzymatic and hormonal signalling cascade leading
to the prepartal output of luteolytic PGF2a. The knowl-
edge, however, about mechanisms governing the develop-
ment of canine placenta is very limited. Locally, at least
in part, the process of decidualization and placentation in
the bitch seems to be regulated by the PGTS2-derived
arachidonic acid metabolites and their receptors [8,38].
One of the well characterized markers of the deciduali-
zation process is the expression of PRL and its receptor
within the endometrium [40]. In the presented study the
uterine expression of PRLr was localized to the surface
and glandular epithelial cells. Thus, it can be speculated
that in the dog PRLr might impact endometrial glandular
secretory function utilizing endo- and/or paracrine
mechanisms possibly playing a role in production of uter-
ine milk (histiotrophe) as it has been suggested for human
[41].
Furthermore, we conclude that the increase of PRLr-
mRNA expression in the utero/placental compartment
observed following the implantation must result from the
upregulated PRLr levels within the placental compartment
as the uterine expression of PRLr did not vary throughout
the course of pregnancy. Immunohistochemistry and in
situ hybridization localized expression of placental PRLr to
epithelial trophoblast cells. Thus a role of PRL in the pla-
cental development possibly through influencing the inva-
sion of fetal trophoblast cells, is strongly implied.
Recently the antigestagen-mediated effects on the luteal
and placental prostaglandin-system have been shown [8,9].
Blocking of luteal and placental progesterone receptors
during mid-pregnancy resulted in activation of the luteoly-
tic cascade in a similar manner as observed during physio-
logical prepartal luteolysis [8,9,42]. In this context, an
interesting observation from this study is the effect of
application of Aglepristone® on PRLr expression in CL
and utero/placental compartment, which mirrored the
situation observed during prepartal luteolysis. Even if any
functional interpretation at this moment would be prema-
ture, we found it an interesting observation suggesting a
functional interrelationship between these two factors also
with respect to the prepartal luteolysis.
Conclusions
In summary, our study is the first to show the expression
of PRLr in canine reproductive tissues. It puts a new focus
on PRL not only as a key luteotropic factor involved in
maintaining luteal steroidogenic activity in the dog but
also as a factor potentially involved in regulating the
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Figure 4 Expression of PRLr as determined by Real Time
(TaqMan) PCR (mean ± SD) in the interplacental polar zones
(interplacental sites of uterus) from the pre-implantation
period until mid-gestation (A) and during Aglepristone®-
induced luteolysis (B; compared with the mid-gestation group
as non-treated control).
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Figure 5 Immunohistochemical (IHC) localization of PRLr in the uterus pre-implantation and in the utero/placental compartment. (A, B)
IHC localization of PRLr in canine endometrium at the pre-implantation stage of pregnancy. (C, D) IHC localization of PRLr within the utero/
placental compartment (mid-gestation). (E, F) Localization of PRLr-mRNA in utero/placental compartment by in situ hybridization (ISH). (A, B) Pre-
implantation PRLr is localized to the endometrial surface epithelial cells (solid arrowheads) and glandular epithelial cells of the superficial (open
arrowheads) and deep (solid arrows) uterine glands. (C, D) Within the utero/placental compartment signals are localized to the endometrial
glands including the superficial glands (solid arrowheads) (the so-called glandular chambers) and to the fetal trophoblast cells (open arrows). (E,
F) The same localization pattern was observed at the mRNA-level by ISH. Thus, strong signals are localized to the trophoblast cells (open arrows)
including those strongly invading maternal blood vessels at the base of placental labyrinth (open arrows).
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uterine and placental function and hence having influence
on embryo survival in this species.
A new insight into PRL-mediated regulatory mechan-
isms has been provided by showing the time dependent
expression of PRLr in canine CL. This led us to specu-
late on the role of the PRLr-dependent cellular signal-
ling pathways in regulating the provision of luteal P4 in
the bitch.
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